Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Celularity, Inc. (CELU) had Revenue of $54.22M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$54.22M
Net Income	$-57.89M
Cost of Goods Sold	$14.99M
Gross Profit	$39.23M
Operating Expenses	$92.58M
Operating Income	$-38.36M
Non-Operating Income/Expense	$-19.53M
Pre-Tax Income	$-57.89M
Normalized Pre-Tax Income	$-57.89M
Income after Taxes	$-57.89M
Income from Continuous Operations	$-57.89M
Consolidated Net Income/Loss	$-57.89M
Normalized Income after Taxes	$-57.89M
EBIT	$-38.36M
EBITDA	$-30.44M
Weighted-Average Shares Outstanding (Basic)	21.89M
Weighted-Average Shares Outstanding (Diluted)	21.89M
Earnings per Share (EPS) (Basic)	$-2.64
Earnings per Share (EPS) (Diluted)	$-2.64
Balance Sheet Financials
Current Assets	$20.56M
Property, Plant, and Equipment	$61.60M
Long-Term Assets	$112.12M
Total Assets	$132.68M
Current Liabilities	$53.68M
Long-Term Debt	$35.93M
Long-Term Liabilities	$70.17M
Total Liabilities	$123.84M
Common Equity	$8.84M
Tangible Shareholders Equity	$-7.76M
Shareholders Equity	$8.84M
Common Shares Outstanding	22.55M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.40M
Cash Flow from Investing Activities	$0.51M
Cash Flow from Financial Activities	$6.70M
Beginning Cash	$10.16M
End Cash	$10.98M
Increase/Decrease in Cash	$0.81M
Stock-Based Compensation	$11.57M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.38
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.80
Debt to Equity Ratio	4.79
Gross Margin	72.36%
Operating Margin	-70.75%
EBIT Margin	-70.75%
EBITDA Margin	-56.13%
Pre-Tax Profit Margin	-106.77%
Profit Margin	-106.77%
Free Cash Flow	$-6.56M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.41
Inventory Turnover	2.77
Receiveable Turnover	4.00
Days Sales in Receivables	91.26
Return on Equity	-655.11%
Return on Tangible Equity	746.22%
Return on Assets	-43.63%
Return on Investments	-129.33%
Book Value Per Share	$0.39
Free Cash Flow per Share	$-0.30
Operating Cash Flow per Share	$-0.29

Data from Zacks Investment Research, Inc.